Breo ellipta 200-25 MCG inhalr 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1ND
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,730
Award facts
- Contract value 100% obligated
- $45,729.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 29, 2026, the Defense Logistics Agency awarded a delivery order valued at $45,729.58 to AmerisourceBergen Drug Corp for the supply of Breo Ellipta 200-25 mcg inhalers (60-count units). This firm fixed-price delivery order, which is not set-aside, represents performance through January 30, 2026, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a critical pharmaceutical distributor supporting federal medical procurement, particularly for military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 comprehensive vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical commodities globally. The parent company, Cencora, Inc., maintains an even larger IDC with DLA valued up to $999,999,999 through December 2031, reflecting the company's significant role in the federal pharmaceutical supply chain. As a non-set-aside award, this delivery order was competitively awarded and demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements across diverse therapeutic domains supporting military treatment facilities and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FA1ND?
SPE2DR26FA1ND was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FA1ND worth?
The government has obligated $45,730 on SPE2DR26FA1ND.
Is contract SPE2DR26FA1ND an order under another contract?
Yes. SPE2DR26FA1ND is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1ND competed?
The extent of competition for SPE2DR26FA1ND was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award